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CFTR Gene Mutations in Men with Bilateral
Ejaculatory-Duct Obstruction and Anomalies
of the Seminal Vesicles
To the Editor:
Mutations in the cystic fibrosis transmembrane conduc-
tance regulator (CFTR) gene have a broad spectrum of
phenotypic manifestations (Kerem and Kerem 1996;
Stern 1997). Classical cystic fibrosis (CF) represents only
the most severe end of the clinical spectrum. A host of
milder CFTR-associated conditions exist, characterized
either by a milder and less progressive natural course
(Strong et al. 1991) or by limitation of manifestations
to a single organ system. Congenital bilateral absence
of the vas deferens (CBAVD) is an example of the latter
category. In this condition, which presents clinicallywith
obstructive azoospermia in otherwise healthy men,
CFTR mutations are currently detected in 70%–80% of
tested individuals (De Braekeleer and Fe´rec 1996).
Men with CBAVD and also with full-blown CF com-
monly have various anomalies of the seminal vesicles,
such as aplasia, hypoplasia, or cystic dilatation (Olson
and Weaver 1969; Holsclaw et al. 1971; Honig et al.
1991). Also, autopsy studies have revealed that males
with CF may have no anatomically discernible ejacu-
latory ducts (Olson and Weaver 1969; Holsclaw et al.
1971). Given the common embryological origin of these
structures from the mesonephric ducts (Larsen 1993), it
is not surprising to find combined abnormalities of vasa
deferentia, epididymides, seminal vesicles, and ejacula-
tory ducts.
Some infertile men with anomalies of the seminal ves-
icles do not have concurrent vas deferens and epididymal
malformations, a condition termed “isolated anomalies
of the seminal vesicles” (IASV). Furthermore, seminal-
vesicle anomalies may be encountered in association
with bilateral ejaculatory duct obstruction (BEDO), an-
other important cause of obstructive azoospermia (Pryor
and Hendry 1991; Meacham et al. 1993). We hypoth-
esized that, similar to CBAVD, IASV and BEDO with
concomitant seminal-vesicle anomalies might represent
two other CFTR-associated diseases confined to themale
genital tract. We analyzed the CFTR gene in 23 patients
with either of these two rare disorders.
All subjects presented for treatment of infertility.
Nineteen of the tested individuals were German, two
came from Turkey, one came from the former Yugosla-
via, and one came from Italy. Evidence for seminal-ves-
icle dysfunction was obtained by semen analysis and
transrectal ultrasound (Behre et al. 1997). Indicators of
seminal vesicle dysfunction, obstruction, or aplasia are
ejaculate that has subnormal volume (!2 ml), low fruc-
tose content (!13 mmol/ejaculate), and pH !7.2. Trans-
rectal ultrasound was performed in most patients, to
directly demonstrate anatomical anomalies of the sem-
inal vesicles (Behre et al. 1995). For the diagnosis of
IASV, three criteria needed to be fulfilled: (1) evidence
of seminal-vesicle malformation, dysfunction or obstruc-
tion as described above, (2) exclusion of an obstruction
of the seminal tract at the level of the vasa deferentia or
epididymides, and (3) no evidence of major damage to
the testicular parenchyma. Criteria (2) and (3) were dem-
onstrated by clinical and ultrasound examination of the
scrotal contents; measurement of a-glucosidase in sem-
inal plasma, as a marker of epididymal function and
patency (Cooper et al. 1990); by measurement of serum
FSH; and, in selected cases, by surgical exploration of
the scrotum and by testis biopsy. BEDO with concom-
itant seminal-vesicle anomalies was diagnosed when (a)
the aforementioned criteria for IASV were fulfilled and
(b) semen analysis showed azoospermia. If, under such
circumstances, the scrotal parts of the vasa deferentia
are palpable (or can be demonstrated to be intact on
surgical exploration), this is pathognomonic of BEDO
(Pryor and Hendry 1991).
DNA was isolated from peripheral lymphocytes, and
target sequences were amplified by PCR. Direct testing
by allele-specific amplification, heteroduplex analysis, or
by restriction analysis was performed in all patients, for
detection of the following CFTR gene mutations:
R117H, R347P, DI507, DF508, 1717-1 GrA, G542X,
G551D, R553X, 384910 kB, W1282X, and N1303K.
The length of the polymorphic polythymidine tract (al-
leles T5, T7, and T9) in the intron 8/exon 9 splice-ac-
ceptor site was determined by sequencing. The T5 allele
interferes with the splicing process of CFTR mRNA
(Chu et al. 1993). It is common among men with
CBAVD (De Braekeleer and Fe´rec 1996) and may here,
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Table 1
Summary of Mutation Analysis in CFTR Gene in 16 Men with IASV
and in 7 Men with BEDO
Diagnosis CFTR Genotypea T5/T7/T9
IASV / 7/7
IASV / 7/7
IASV / 7/7
IASV / 7/7
IASV / 7/7
IASV / 7/7
IASV / 7/9
IASV / 7/7
IASV / 7/7
IASV / 7/7
IASV / 7/7
IASV / 5/7
IASV / 7/7
IASV / 7/7
IASV I1139V/ 7/9
IASV / 7/7
BEDO DF508/ 9/5
BEDO DF508/R117H 9/7
BEDO / 7/9
BEDO DF508/R117H 9/7
BEDO R553X/ 7/5
BEDO R347P/ 7/7
BEDO DF508/ 9/5
a A plus sign () denotes the wild-type allele (i.e., no mutation was
detected).
in conjunction with a full-blown mutation, act as a mu-
tation equivalent. If direct testing yielded no or only one
mutation or T5 allele, the search was extended by de-
naturing gradient gel electrophoresis (DGGE [Costes et
al. 1994]) comprising all 27 CFTR exons in the first
seven patients and exons 3, 5, 6a, 8, 11, 12, 14a, 14b,
15, 17bi, 18, 20, 21, and 23 in the remaining 16. If
abnormal bands were detected, direct sequencing of the
respective exon followed.
Table 1 summarizes the results of the mutation anal-
ysis. Among the 16 patients from the IASV group, 1
subject was found to be heterozygous for the rare CF
mutation I1139V (Teng et al. 1994), and another was
found to be heterozygous for the T5 allele. In the BEDO
group, six of seven men were mutation positive (when
the T5 allele was considered as a mutation). Compound
heterozygosity for DF508/R117H was detected in two
patients, for DF508/T5 in another two, and for R553X/
T5 in one. One man was heterozygous for R347P. For
one of the five compound heterozygotes, parental DNA
could be obtained. His father carries the DF508 muta-
tion, and his mother carries the R117H mutation, prov-
ing that in the index patient the two mutations are in
the trans phase.
Approximately 4% of healthy subjects from northern
European populations carry a CF allele (Boat et al.
1989), and the prevalence of T5 is 3%–5% (De Brae-
keleer and Fe´rec 1996). The two positive cases in the
IASV group might well represent coincidental findings,
and, given the absence of detectable mutations in the
other 15 men from this group, it appears unlikely that
IASV is caused by mutations in the CFTR gene. How-
ever, the possibility that IASV is an etiologically heter-
ogeneous condition and that only a subgroup of these
patients harbor CFTR mutations cannot be ruled out
definitely. Six of seven men with BEDO and concomitant
seminal vesicle anomalies were identified as carriers of
CFTR-gene mutations. We suggest that these mutations
are the molecular basis of the genital-tract anomalies
and the resulting infertility in our patients. Similar to
CBAVD, BEDOwith concomitant seminal-vesicle anom-
alies thus may be regarded as a CFTR-associated dis-
order confined to the male genital tract. The spectrum
of mutations encountered in CBAVD and in BEDO with
concomitant seminal-vesicle anomalies overlaps consid-
erably. R117H and the T5 allele are rarely found in full-
blown CF, but they contribute to a major degree to the
molecular pathology underlying both CBAVD (De Brae-
keleer and Fe´rec 1996) and BEDO with concomitant
seminal-vesicle anomalies.
In anatomical and etiological terms BEDO is a het-
erogeneous disorder (Pryor andHendry 1991;Meacham
et al. 1993); it may be either partial or complete, and
only the latter leads to azoospermia. BEDO may be sec-
ondary to pelvic trauma and surgery, infections, pro-
static neoplasms, or Mu¨llerian-duct cysts (Pryor and
Hendry 1991; Honig 1994). None of these possible eti-
ologies could be identified among the cases from the
present series. In our patients, both the obstruction of
the ejaculatory ducts and the concomitant seminal-ves-
icle anomalies most likely represent primary malfor-
mations or functional abnormalities of mesonephric-
duct origin.
With the support of assisted-fertilization techniques,
patients with BEDO are now able to father children
(Silber et al. 1995). Their offspring must be regarded as
being at increased risk for CF. The carrier frequency for
CF is 4%–5% in many countries, so the female partner
of an infertile man with BEDO may be heterozygous
purely by chance. To recognize such a high-risk situa-
tion, especially when treatment with assisted reproduc-
tive technology is planned, CFTR-gene mutation anal-
ysis should be considered in patients with BEDO and
concomitant seminal-vesicle anomalies.
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Mutations in the TIGR Gene in Familial Primary
Open-Angle Glaucoma in Japan
To the Editor:
As described in an editorial by Raymond (1997), glau-
coma is characterized by progressive excavation of the
optic disk, with both loss of retinal nerve fiber and visual
field defects. This disease is one of the most common
causes of bilateral blindness, and it is estimated that by
the year 2000 ∼66.8 million people worldwide will be
affected by it (Quigley 1996). Recently, the glaucoma
geneGLC1A was shown to be identical to the trabecular
meshwork–inducible glucocorticoid response (TIGR)
gene (TIGR) (Stone et al. 1997). The TIGR gene was
cloned by Polansky and colleagues (Nguyen et al. 1993;
Polansky et al. 1997) and, also, was called “myocilin”
(gene MYOC) when it was cloned by Kubota et al.
(1997). Three different mutations in the gene were
shown to be responsible for the development of primary
open-angle glaucoma (POAG), the most common form
of glaucoma (Stone et al. 1997). The prevalence of these
mutations was reported to be 4.4% in familial POAG
patients and 2.9% in unselected POAG patients (Stone
et al. 1997). We investigated whether Japanese patients
with familial POAG carry identical or other mutants on
the same gene. As a result, two new mutations in the
TIGR gene were found. The prevalence of mutations in
the TIGR gene in Japanese patients with familial POAG
was also investigated.
Peripheral blood samples were collected, with in-
